CAV1 and breast carcinoma: Our findings thus provide novel insights into the molecular mechanisms controlling autophagosome biogenesis via SNARE protein in recycling endosomes under the regulation of CEMMs, and the potential clinical target for breast cancer patients with reduced CAV1 expression who develop Doxo resistance.